Nasdaq · Healthcare
Medline Inc. (MDLN)
As-reported financials and recent SEC filings for Medline Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$28.43B
Net income
$1.16B
Net margin
4.1%
Diluted EPS
$-0.01
ROE
6.0%
P/E (TTM)
34.1×
Market cap
$69.26B
Debt / equity
0.6×
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 | FY2025 |
|---|---|---|---|---|
| Revenue | $28.43B | — | $25.51B | $23.23B |
| Gross profit | $7.52B | — | $6.98B | $5.88B |
| Operating income | $2.21B | — | $2.15B | $1.25B |
| Net income | $1.16B | $1.15B | $1.16B | $234.0M |
| Diluted EPS | $-0.01 | — | — | — |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →Go deeper on MDLN
Search Medline Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.